Axisresearch
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
Currently, the global SSI control market is in the growing phase and is dominated by hospitals and developed regions, like North America. Increasing hospital-acquired infections and number of surgeries are increasingly driving the SSI control market across the world. Increased focus on preventing SSI through appropriate measures has further augmented the market in developed regions. Awareness about surgical site infections is also higher in the developed regions. This has led to higher adoption of SSI control products, thus, preventing infections among people. The increasing geriatric population has also impacted this market positively.
Scope of the Report
As per the scope of this report, surgical site infection (SSI) is an infection that occurs after surgery, in that part of the body where the surgery has been done. Surgical site infections can be superficial, deep incisional, or organ related.
Key Market Trends
Superficial Incisional SSI Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
Surgical site infection (SSI) represents the most common nosocomial infection and accounts for about 15% of all nosocomial infections. Surgical site infection is one of the most common complications of gastrointestinal surgery. This type of surgical procedures and wound closure methods affect the incidence of superficial incisional surgical site infection. There is an increase in the incidence of superficial incisional SSI infections, as compared to deep incisional SSI and organ or space SSIs.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America dominated the surgical site infection control market, with the United States contributing the largest share in the regional revenue. SSIs are considered the most common (tied with pneumonia) healthcare-associated infection (HAI) among inpatients in acute care hospitals in the United States. SSIs occur in an estimated 2-5% of patients undergoing inpatient surgery. The estimated annual incidence of SSIs in the United States ranges from 160,000 to 300,000, and the estimated annual cost ranges from USD 3.5 billion to USD 10 billion. Hence, the rising need for the prevention of SSI can be attributed to the rising number of surgical procedures performed in the United States.
Competitive Landscape
3M Company, Becton, Dickinson and Company, Biomerieux SA, Getinge Grou,p and Johnson & Johnson are some of the major players in the surgical site infection control market The competitive rivalry of the market studied has intensified, owing to the constant product innovations across the world.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Hospital Acquired Infection
4.2.2 Regulatory Guidelines for Hospital Infection Prevention and Control
4.2.3 Increasing Number of Surgeries
4.2.4 Rapidly Growing Geriatric Population
4.3 Market Restraints
4.3.1 Lack of Awareness of Hospital Infection Prevention and Control
4.3.2 Increased Use of Outpatient Treatment
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Manual Reprocessors Solution
5.1.2 Disinfectants
5.1.2.1 Hand Disinfectants
5.1.2.2 Skin Disinfectants
5.1.3 Surgical Scrubs
5.1.4 Hair Clippers
5.1.5 Surgical Drapes
5.1.6 Surgical Irrigation
5.1.7 Skin Preparation Solution
5.1.8 Medical Nonwovens
5.1.9 Surgical Gloves
5.1.10 Other Products
5.2 By Surgery/Procedure
5.2.1 Cataract Surgery
5.2.2 Cesarean Section
5.2.3 Dental Restoration
5.2.4 Gastric Bypass
5.2.5 Other Surgeries/Procedures
5.3 By Type of Infection
5.3.1 Superficial Incisional SSI
5.3.2 Deep Incisional SSI
5.3.3 Organ or Space SSI
5.4 By End User
5.4.1 Hospitals
5.4.2 Ambulatory Surgical Centers
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M
6.1.2 Becton, Dickinson and Company
6.1.3 Belimed AG
6.1.4 bioMerieux SA
6.1.5 Getinge Group
6.1.6 Johnson & Johnson
6.1.7 Kimberly-Clark Corporation
6.1.8 Sotera Health
6.1.9 Ansell Limited
6.1.10 Steris Corporation
6.1.11 Lac-Mac Limited
6.1.12 Pacon Manufacturing Corp.
6.1.13 American Polyfilm Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Manual Reprocessors Solution
Disinfectants
Hand Disinfectants
Skin Disinfectants
Surgical Scrubs
Hair Clippers
Surgical Drapes
Surgical Irrigation
Skin Preparation Solution
Medical Nonwovens
Surgical Gloves
Other Products
By Surgery/Procedure
Cataract Surgery
Cesarean Section
Dental Restoration
Gastric Bypass
Other Surgeries/Procedures
By Type of Infection
Superficial Incisional SSI
Deep Incisional SSI
Organ or Space SSI
By End User
Hospitals
Ambulatory Surgical Centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America